Overview

UH3 Varenicline for Cannabis Use Disorder

Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
Marijuana is the most commonly used illicit drug. There is high demand for effective interventions for cannabis use disorder, yet few specific treatments for have been developed. This study will evaluate the efficacy of varenicline for reducing marijuana use in people who use marijuana frequently.
Phase:
Phase 2
Details
Lead Sponsor:
Medical University of South Carolina
Treatments:
Varenicline